Friday, June 26, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 811 of 1,261
  1. US 8748657

    Process to prepare treprostinil

    United Therapeutics Corporation · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted
  2. US 8748648

    Oligomer-calcium channel blocker conjugates

    Nektar Therapeutics · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted
  3. US 8748176

    Generation of choroid plexus epithelial cells from human embryonic stem cells

    The Regents of the University of California · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted
  4. US 8748385

    Adult cerebellum-derived neural stem cells and compositions and methods for producing oligodendrocytes

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted
  5. US 8748572

    RNase a peptides, fragments and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted
  6. US 8748442

    sGC stimulators

    IRONWOOD PHARMACEUTICALS, INC. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted
  7. US 8747897

    Osmotic drug delivery system

    Supernus Pharmaceuticals, Inc. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted
  8. US 8741649

    Methods for enhancing genome stability and telomere elongation in embryonic stem cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  9. US 8741880

    Antiglucocorticoid therapy for the prevention of neurological damage in premature infants

    Corcept Therapeutics Incorporated · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  10. US 8741898

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  11. US 8741937

    Gamma glutamyl transpeptidase inhibitors and methods of use

    The Board of Regents of the University of Oklahoma · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  12. US 8742121

    Process for the preparation of small molecule inhibitors of MDM2 and intermediates used therein

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  13. US 8740872

    Magnetically-targeted treatment for cardiac disorders

    The Board of Regents of the University of Oklahoma · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  14. US 8741922

    Solid forms of N-(4-(7-azabicyclo[2.2,1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  15. US 8741939

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  16. US 8742109

    Synthetic methods for spiro-oxindole compounds

    Xenon Pharmaceuticals Inc. · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  17. US 8741925

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  18. US 8741933

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  19. US 8741947

    Biologically active macrolides, compositions, and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  20. US 8742119

    Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use

    Agios Pharmaceuticals, Inc. · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  21. US 8742129

    Crystalline forms of febuxostat

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  22. US 8742131

    7-azoniabicyclo [2.2.1] heptane derivatives, methods of production, and pharmaceutical uses thereof

    THERON PHARMACEUTICALS, INC. · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  23. US 8742134

    7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof

    THERON PHARMACEUTICALS, INC. · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  24. US 8741309

    Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142

    The United States of America, as represented by the Secretary of Agriculture · Granted Jun 3, 2014 · Expires May 29, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.